(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.The insulin pump involved in this event is the 640g insulin infusion pump, which is not marketed in the united states.However, the device is similar to the paradigm real-time insulin infusion pump, which is marketed in the united states.
|
S/w 2.9d retainer = clear case type ngp the pump was returned for pump error 18, 19 and 130 alarm found on 10/16/2022.Unit passed the displacement test, rewind test, prime/seating test, basic occlusion test, force sensor test, and occlusion test.Pump was cut open to perform visual inspection and found moisture damage on the pcba 1 / pcba 2 / force sensor, 40 pin flexible printed circuit/lcd and motor.Successfully downloaded firmware using crest.Pump error 130 alarm confirmed in history file or traces (b)(6) 2022 14:30:54:000 pm, pump error 18 on (b)(6) 2022 14:55:52:000 pm and pump error 19 on (b)(6) 2022 14:51:41:000 pm due to moisture damage on the force sensor.The following were noted during visual inspection cracked retainer, cracked battery tube threads, fading serial number label, and cracked case corner of belt clip rails.The unit p-cap / test reservoir locks in place properly.Unit was confirmed for pump error 130, 18 and 19 alarms due to moisture damage.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|